[1]
Neagu, A. et al. 2022. Cardiac toxicity of EGFR – 3rd generation TKI in patients with metastatic non-small cell lung cancer. Case report and literature data update. Technium BioChemMed. 4, 1 (Dec. 2022), 10–16. DOI:https://doi.org/10.47577/biochemmed.v4i1.7962.